<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32969204</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2326-5205</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title><ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Interactions Between Genome-Wide Genetic Factors and Smoking Influencing Risk of Systemic Lupus Erythematosus.</ArticleTitle><Pagination><StartPage>1863</StartPage><EndPage>1871</EndPage><MedlinePgn>1863-1871</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.41414</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To identify interactions between genetic factors and current or recent smoking in relation to risk of developing systemic lupus erythematosus (SLE).</AbstractText><AbstractText Label="METHODS">For the study, 673 patients with SLE (diagnosed according to the American College of Rheumatology 1997 updated classification criteria) were matched by age, sex, and race (first 3 genetic principal components) to 3,272 control subjects without a history of connective tissue disease. Smoking status was classified as current smoking/having recently quit smoking within 4 years before diagnosis (or matched index date for controls) versus distant past/never smoking. In total, 86 single-nucleotide polymorphisms and 10 classic HLA alleles previously associated with SLE were included in a weighted genetic risk score (wGRS), with scores dichotomized as either low or high based on the median value in control subjects (low wGRS being defined as less than or equal to the control median; high wGRS being defined as greater than the control median). Conditional logistic regression models were used to estimate both the risk of SLE and risk of anti-double-stranded DNA autoantibody-positive (dsDNA+) SLE. Additive interactions were assessed using the attributable proportion (AP) due to interaction, and multiplicative interactions were assessed using a chi-square test (with 1 degree of freedom) for the wGRS and for individual risk alleles. Separate repeated analyses were carried out among subjects of European ancestry only.</AbstractText><AbstractText Label="RESULTS">The mean &#xb1; SD age of the SLE patients at the time of diagnosis was 36.4 &#xb1; 15.3 years. Among the 673 SLE patients included, 92.3% were female and 59.3% were dsDNA+. Ethnic distributions were as follows: 75.6% of European ancestry, 4.5% of Asian ancestry, 11.7% of African ancestry, and 8.2% classified as other ancestry. A high wGRS (odds ratio [OR] 2.0, P = 1.0 &#xd7; 10<sup>-51</sup> versus low wGRS) and a status of current/recent smoking (OR 1.5, P = 0.0003 versus distant past/never smoking) were strongly associated with SLE risk, with significant additive interaction (AP 0.33, P = 0.0012), and associations with the risk of anti-dsDNA+ SLE were even stronger. No significant multiplicative interactions with the total wGRS (P = 0.58) or with the HLA-only wGRS (P = 0.06) were found. Findings were similar in analyses restricted to only subjects of European ancestry.</AbstractText><AbstractText Label="CONCLUSION">The strong additive interaction between an updated SLE genetic risk score and current/recent smoking suggests that smoking may influence specific genes in the pathogenesis of SLE.</AbstractText><CopyrightInformation>&#xa9; 2020, American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Jing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8657-1741</Identifier><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raychaudhuri</LastName><ForeName>Soumya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlson</LastName><ForeName>Elizabeth W</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Speyer</LastName><ForeName>Cameron</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malspeis</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Hongshu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparks</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-5556-4618</Identifier><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Hongru</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevens</LastName><ForeName>Emma</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0338-4439</Identifier><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Jessica N</ForeName><Initials>JN</Initials><Identifier Source="ORCID">0000-0002-1134-9625</Identifier><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davenport</LastName><ForeName>Emma E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knevel</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7494-3023</Identifier><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costenbader</LastName><ForeName>Karen H</ForeName><Initials>KH</Initials><Identifier Source="ORCID">0000-0002-8972-9388</Identifier><AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UM1 AI109565</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 CA087969</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AR066109</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AR007530</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR049880</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR063759</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL088521</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA049449</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA067262</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR072577</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR057327</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA176726</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL034594</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 CA186107</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheumatol</MedlineTA><NlmUniqueID>101623795</NlmUniqueID><ISSNLinking>2326-5191</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>24</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32969204</ArticleId><ArticleId IdType="mid">NIHMS1620048</ArticleId><ArticleId IdType="pmc">PMC7722161</ArticleId><ArticleId IdType="doi">10.1002/art.41414</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lotstein DS, Ward MM, Bush TM, Lambert RE, van Vollenhoven R, Neuwelt CM. Socioeconomic status and health in women with systemic lupus erythematosus. The Journal of rheumatology. 1998;25(9):1720&#x2013;1729.</Citation><ArticleIdList><ArticleId IdType="pubmed">9733452</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo CF, Grainge MJ, Valdes AM, et al. Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families. JAMA internal medicine. 2015;175(9):1518&#x2013;1526.</Citation><ArticleIdList><ArticleId IdType="pubmed">26193127</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld CD, Ainsworth HC, Cunninghame Graham DS, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nature communications. 2017;8:16021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520018</ArticleId><ArticleId IdType="pubmed">28714469</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentham J, Morris DL, Graham DSC, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nature genetics. 2015;47(12):1457&#x2013;1464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4668589</ArticleId><ArticleId IdType="pubmed">26502338</ArticleId></ArticleIdList></Reference><Reference><Citation>Gateva V, Sandling JK, Hom G, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nature genetics. 2009;41(11):1228&#x2013;1233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2925843</ArticleId><ArticleId IdType="pubmed">19838195</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris DL, Sheng Y, Zhang Y, et al. Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus. Nature genetics. 2016;48(8):940&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4966635</ArticleId><ArticleId IdType="pubmed">27399966</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Shimane K, Kochi Y, et al. A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus eyrthematosus in Japanese. PLoS genetics. 2012;8(1):e1002455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3266877</ArticleId><ArticleId IdType="pubmed">22291604</ArticleId></ArticleIdList></Reference><Reference><Citation>International Consortium for Systemic Lupus Erythematosus G, Harley JB, Alarcon-Riquelme ME, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature genetics. 2008;40(2):204&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712260</ArticleId><ArticleId IdType="pubmed">18204446</ArticleId></ArticleIdList></Reference><Reference><Citation>Costenbader KH, Kim DJ, Peerzada J, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis and rheumatism. 2004;50(3):849&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">15022327</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbhaiya M, Tedeschi SK, Lu B, et al. Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses' Health Study cohorts. Annals of the rheumatic diseases. 2018;77(2):196&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5994168</ArticleId><ArticleId IdType="pubmed">28988206</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet. 2001;358(9290):1356&#x2013;1360.</Citation><ArticleIdList><ArticleId IdType="pubmed">11684236</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlson EW, Sanchez-Guerrero J, Wright EA, et al. A connective tissue disease screening questionnaire for population studies. Annals of epidemiology. 1995;5(4):297&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">8520712</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and rheumatism. 1997;40(9):1725.</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271&#x2013;1277.</Citation><ArticleIdList><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Merola JF, Bermas B, Lu B, et al. Clinical manifestations and survival among adults with (SLE) according to age at diagnosis. Lupus. 2014;23(8):778&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4157121</ArticleId><ArticleId IdType="pubmed">24608964</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlson EW, Boutin NT, Hoffnagle AG, Allen NL. Building the Partners HealthCare Biobank at Partners Personalized Medicine: Informed Consent, Return of Research Results, Recruitment Lessons and Operational Considerations. Journal of personalized medicine. 2016;6(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810381</ArticleId><ArticleId IdType="pubmed">26784234</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Han B, Onengut-Gumuscu S, et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One. 2013;8(6):e64683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675122</ArticleId><ArticleId IdType="pubmed">23762245</ArticleId></ArticleIdList></Reference><Reference><Citation>Danecek P, Auton A, Abecasis G, et al. The variant call format and VCFtools. Bioinformatics (Oxford, England). 2011;27(15):2156&#x2013;2158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137218</ArticleId><ArticleId IdType="pubmed">21653522</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntzani EE, Liberopoulos G, Manolio TA, Ioannidis JP. Consistency of genome-wide associations across major ancestral groups. Human genetics. 2012;131(7):1057&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pubmed">22183176</ArticleId></ArticleIdList></Reference><Reference><Citation>Marigorta UM, Navarro A. High trans-ethnic replicability of GWAS results implies common causal variants. PLoS genetics. 2013;9(6):e1003566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3681663</ArticleId><ArticleId IdType="pubmed">23785302</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Ahlford A, Jarvinen TM, et al. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur J Hum Genet. 2013;21(9):994&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3746253</ArticleId><ArticleId IdType="pubmed">23249952</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. European journal of epidemiology. 2005;20(7):575&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">16119429</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Jiang X, Cui J, et al. Interactions between amino acid-defined major histocompatibility complex class II variants and smoking in seropositive rheumatoid arthritis. Arthritis &amp; rheumatology (Hoboken, NJ. 2015;67(10):2611&#x2013;2623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4581918</ArticleId><ArticleId IdType="pubmed">26098791</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SS, Rosenberg PS, Garcia-Closas M, et al. Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data. American journal of epidemiology. 2012;176(11):1060&#x2013;1067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3571244</ArticleId><ArticleId IdType="pubmed">23118105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Wang M, Tyrer JP, et al. A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants. International journal of cancer. 2019;144(9):2192&#x2013;2205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6399057</ArticleId><ArticleId IdType="pubmed">30499236</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlson EW, Chang SC, Cui J, et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Annals of the rheumatic diseases. 2010;69(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2952498</ArticleId><ArticleId IdType="pubmed">19151010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallberg H, Ahlbom A, Alfredsson L. Calculating measures of biological interaction using R. European journal of epidemiology. 2006;21(8):571&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pubmed">16969718</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Wang YF, Liu L, et al. Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity. Human molecular genetics. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7322569</ArticleId><ArticleId IdType="pubmed">32077931</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid S, Alexsson A, Frodlund M, et al. High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus. Annals of the rheumatic diseases. 2020;79(3):363&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7034364</ArticleId><ArticleId IdType="pubmed">31826855</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparks JA, Costenbader KH. Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases. Rheum Dis Clin North Am. 2014;40(4):637&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4250576</ArticleId><ArticleId IdType="pubmed">25437282</ArticleId></ArticleIdList></Reference><Reference><Citation>Pryor WA SK. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. . Ann N Y Acad Sci. 1993;686:12&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">8512242</ArticleId></ArticleIdList></Reference><Reference><Citation>Walczak H, Krammer PH. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res. 2000;256(1):58&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">10739652</ArticleId></ArticleIdList></Reference><Reference><Citation>Leatherwood C, Liu X, Malspeis S, et al. Associations between Current Cigarette Smoking and SLE-Related Cytokine and Chemokine Biomarkers Among U.S. Female Nurses without SLE [abstract]. Arthritis and Rheumatology. 2018;70.</Citation></Reference><Reference><Citation>Lundstrom E, Kallberg H, Alfredsson L, Klareskog L, Padyukov L. Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis and rheumatism. 2009;60(6):1597&#x2013;1603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2732897</ArticleId><ArticleId IdType="pubmed">19479873</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyohara C, Washio M, Horiuchi T, et al. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population. Lupus. 2009;18(7):630&#x2013;638.</Citation><ArticleIdList><ArticleId IdType="pubmed">19433464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyohara C, Washio M, Horiuchi T, et al. Cigarette smoking, STAT4 and TNFRSF1B polymorphisms, and systemic lupus erythematosus in a Japanese population. The Journal of rheumatology. 2009;36(10):2195&#x2013;2203.</Citation><ArticleIdList><ArticleId IdType="pubmed">19684152</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyohara C, Washio M, Horiuchi T, et al. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population. Scandinavian journal of rheumatology. 2012;41(2):103&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">22217397</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon PH, Sylvestre MP, Tremblay J, Hamet P. Key Considerations and Methods in the Study of Gene-Environment Interactions. Am J Hypertens. 2015;29(8):891&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pubmed">27037711</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley JB, Alarcon-Riquelme ME, Criswell LA, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature genetics. 2008;40(2):204&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712260</ArticleId><ArticleId IdType="pubmed">18204446</ArticleId></ArticleIdList></Reference><Reference><Citation>Hom G, Graham RR, Modrek B, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358(9):900&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">18204098</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath SK, Han S, Kim-Howard X, et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nature genetics. 2008;40(2):152&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">18204448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozyrev SV, Abelson AK, Wojcik J, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nature genetics. 2008;40(2):211&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">18204447</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JW, Zheng HF, Cui Y, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nature genetics. 2009;41(11):1234&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pubmed">19838193</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Zhao M, Hirankarn N, et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Human molecular genetics. 2009;18(11):2063&#x2013;2070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678927</ArticleId><ArticleId IdType="pubmed">19286673</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Shen N, Ye DQ, et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS genetics. 2010;6(2):e1000841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2820522</ArticleId><ArticleId IdType="pubmed">20169177</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarcon-Riquelme ME, Ziegler JT, Molineros J, et al. Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture. Arthritis &amp; rheumatology (Hoboken, NJ. 2016;68(4):932&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4829354</ArticleId><ArticleId IdType="pubmed">26606652</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanscombe KB, Morris DL, Noble JA, et al. Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans. Human molecular genetics. 2018;27(21):3813&#x2013;3824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6196648</ArticleId><ArticleId IdType="pubmed">30085094</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>